| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.073 | 0.2 |